Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04106115 |
| Title | DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr (DURANCE) |
| Acronym | DURANCE |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | University College, London |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Guy's and St Thomas' NHS Foundation Trust | RECRUITING | London | United Kingdom | Details | ||
| The Royal Marsden NHS Foundation Trust | RECRUITING | London | United Kingdom | Details | ||
| University College London Hospital NHS Foundation Trust | RECRUITING | London | United Kingdom | Details | ||
| The Christie NHS Foundation Trust | RECRUITING | Manchester | United Kingdom | Details | ||
| University Hospital Southampton NHS Foundation Trust | RECRUITING | Southampton | United Kingdom | Details |